Last reviewed · How we verify

Minocycline plus tretinoin — Competitive Intelligence Brief

Minocycline plus tretinoin (Minocycline plus tretinoin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Tetracycline antibiotic + retinoid combination. Area: Dermatology.

marketed Tetracycline antibiotic + retinoid combination Bacterial ribosome (minocycline); retinoic acid receptors (tretinoin) Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Minocycline plus tretinoin (Minocycline plus tretinoin) — Derm Research @ 888 Inc.. Minocycline is a tetracycline antibiotic with anti-inflammatory properties, while tretinoin is a retinoid that promotes skin cell turnover and reduces sebum production; together they target bacterial infection and inflammation in acne.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Minocycline plus tretinoin TARGET Minocycline plus tretinoin Derm Research @ 888 Inc. marketed Tetracycline antibiotic + retinoid combination Bacterial ribosome (minocycline); retinoic acid receptors (tretinoin)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Tetracycline antibiotic + retinoid combination class)

  1. Derm Research @ 888 Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Minocycline plus tretinoin — Competitive Intelligence Brief. https://druglandscape.com/ci/minocycline-plus-tretinoin. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: